BN Business News
Add your company to Business Communicator →

International trade · 23/07/2026Updated: 10/17/2026 · 1 min read

USPTO Grants Interim Extension to Centanafadine Hydrochloride Patent

Summary

The United States Patent and Trademark Office has issued an order granting a one-year extension to the term of U.S. Patent No. 9,737,506, allowing Centanafadine Hydrochloride to maintain its patent protection for an additional year.

Original source language: Federal Register — Department of CommerceOpen original release →

Explore insights

Business insights →